Cargando…
Apremilast as a treatment for morphea: A case series
Autores principales: | Koschitzky, Merav, Khattri, Saakshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669255/ https://www.ncbi.nlm.nih.gov/pubmed/34917727 http://dx.doi.org/10.1016/j.jdcr.2021.11.009 |
Ejemplares similares
-
Eczematous reactions to psoriasis biologics treated with dupilumab: A case series
por: Koschitzky, Merav, et al.
Publicado: (2021) -
Tocilizumab for refractory morphea in adults: A case series
por: Lonowski, Sarah, et al.
Publicado: (2022) -
Apremilast for immune checkpoint inhibitor-induced psoriasis: A case series
por: Mayor Ibarguren, Ander, et al.
Publicado: (2021) -
The Correction of Facial Morphea Lesions by Hyaluronic Acid: A Case Series and Literature Review
por: Owczarczyk-Saczonek, Agnieszka, et al.
Publicado: (2020) -
Superficial morphea: A rare condition and report of three unique cases
por: Bommareddy, Kanthi, et al.
Publicado: (2021)